Auto-antibody levels and history of breast-feeding in type 1 diabetic patients;Perfil de auto-anticuerpos y lactancia materna en pacientes diabéticos tipo 1

Revista Medica de Chile

Volumn 129, Issue 6, 2001, Pages 611-619

  Pérez Bravo, Francisco ^a   Riesco S , M Virginia ^b   Albala B , Cecilia ^b   Oyarzún A , Amaya ^b   Santos M , J Luis ^b   Carrasco P , Elena ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

Antibodies; Breast feeding; Diabetes mellitus; Insulin dependent

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ARTICLE; BLOOD; BREAST FEEDING; CASE CONTROL STUDY; CHILD; CHILE; FEMALE; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEWBORN; NONPARAMETRIC TEST; PRESCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; BREAST FEEDING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHILE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROTEIN-TYROSINE-PHOSPHATASE; STATISTICS, NONPARAMETRIC;

EID: 0035376407     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DORMAN JS. Molecular epidemiology of insulin-dependent diabetes mellitus. Epidemiol Rev 1997; 19: 91-8.
2. AKERBLOM HK, KNIP M, HYOTY H, REIJONEN H, VIRTANEN S, SAVILAHTI E, ILONEN J. Interaction of genetic and environmental factors in the pathogenesis of insulin-dependent diabetes mellitus. Clin Chim Acta 1997; 257: 143-56.
3. LESLIE RDG, ATKINSON MA, NOTKINS AL. Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 1999; 42: 3-14.
4. BINGLEY PJ, BONIFACIO E, WILLIAMS AJK, GENOVESE S, BOTTAZZO GF, GALE EAM. Prediction of IDDM in the general population: strategies based on combination of autoantibody markers. Diabetes 1997; 46: 1701-10.
5. TIAN J, OLCOTT A, HANSSEN L, ZEKZER D, KAUFMAN DL. Antigen-based immunotherapy for autoimmune disease: from animal model to humans?. Immunol Today 1999; 20: 190-4.
6. MORALES J, PUIG-DOMINGO M, LAMPASONA V, CORCOY R, DYRBERG T, MAURICIO D, ET AL. Can we replace ICA? Risk assessment by using fluid phase multiantibody analysis in a prediabetic Spanish cohort. Av Diabetol 1998; 14: 91-8.
7. ATKINSON MA, BOWMAN MA, CAMPBELL L, DARROW BL, KAUFMAN DL, MACLAREN NK. Cellular immunity to a determinant common to glutamate decarboxilase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94: 2125-30.
8. SCHLOOT NC, POZZILLI P, MANDRUP-POULSEN T. Immune markers for monitoring the progression of autoimmune disease. Diabetes Metab Res Rev 1999; 15: 141-5.
9. KUKREJA A, MACLAREN NK. Autoimmunity and Diabetes. J Clin Endocrinol Metab. 1999; 84: 4371-7.
10. PAYTON MA, HAWKES CJ, CHRISTIE MR. Relationship of the 37,000 and 40,000 Mr tryptic fragments of islet antigens in insulin dependent diabetes to the protein tyrosine phosphatase like molecule IA-2 (ICA 512). J Clin Invest 1995; 96: 1506-11.
11. KULMALA P, SAVOLA K, PETERSEN J, VAHASALO P, KARJALAINEN J, LOPPONEN T, ET AL. Prediction of insulin dependent diabetes mellitus in siblings of children with diabetes. A population based study. J Clin Invest 1998; 101: 327-36.
12. MAIZ A, MANRIQUE M, HODGSON MI, DIAZ DE VALDÉS M, ACOSTA AM, ANDRADE L, OLMOS P. Prevalencia de anticuerpos anti islotes pancreáticos en 1021 parientes de diabetes tipo 1. Rev Méd Chile 1999; 127: 515-22.
13. VANDEWALLE CL, FALORNI A, LERNMARK A, GOUBERT P, DORCHY H, COUCKE C, ET AL. Associations of GAD65 and IA-2 autoantibodies with genetic risk markers in new onset IDDM patients and their siblings. Diabetes Care 1997; 20: 1547-52.
14. CHARLES F, VERGE AND GEORGE S. EISENBARTH. Natural History of Autoimmunity in Type 1 DM. In: Derek leRoith (eds). Diabetes Mellitus, 1st ed. Philadelphia, USA 1996; 155-77.
15. BONIFACIO E, GENOVESE S, BRAGHI S, BAZZIGALUPPI E, LAMPASONA V, BINGLEY PJ, ET AL. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-22.
16. HANSON LA. Human milk and host defence: immediate and long-term effects. Acta paediatr 1999; 88: 42-6.
17. AS GOLDMAN. The immune system of human milk: antimicrobial, antiinflammatory and immuno-modulating properties. In: Pediatrics Infectious Disease Journal 1993; 12: 664-71.
18. KOLB H, POZZILLI P. Cow's milk and type 1 diabetes: the gut immune system deserves attention. Immunology Today 1999; 20: 108-10.
19. DAHLQUIST G. The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr 1998; 425 : 5-10.
20. KOLB H. On the aetiopathogenesis of type 1 diabetes: key roles for innate immunity and dietary antigens? Exp Clin Endocrinol Diabetes 1999; 107: 13-16.
21. VAARALA O, KNIP M, PARONEN J, HAMALAINEN AM, MUONA P, VAATAINEN M, ILLONEN J ET AL. Cow's milk formula feeding induce primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999; 48: 1389-94.
22. PILCHER CC, ELLIOT RB. A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Methods 1990; 129: 111-7.
23. CARRASCO E, PÉREZ-BRAVO F, SANTOS JL, LÓPEZ G, CALVILLÁN M, WOLFF C, GARCÍA DE LOS RÍOS M. One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile. Diab. Res Clin Pract 1996; 34: 153-7.
24. CARRASCO E, MONORAGÓN A, SANTOS JL, PÉREZ F. Incidence of type 1 diabetes mellitus under 15 years in Santiago, Chile 1993-1997. Diab Res Clin Pract 2000; 50: S-120.
25. SABBAH E, SAVOLA K, KULMALA P, REIJONEN H, VEIJOLA R, VAHASALO P, ET AL. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Clin Exp Immunol 1999; 116: 78-85.
26. STREBELOW M, SCHOLOSSER M, ZIEGLER B, RJASANOWSKI L, ZIEGLER M. Karlsburg type 1 diabetes risk study of a general population: frequencies and interactions of the four major type 1 diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 1999; 42: 661-70.
27. SCHAID DJ. Case-parents design for gene-environment interaction. Genetic Epi 1999; 6: 201-73.
28. MACLAREN MK. How, when and why to predict IDDM. Diabetes 1988; 37: 1591-6.
29. RILEY WJ. Identification of insulin-dependent diabetes mellitus before onset of clinical symptoms. J Pediatr 1988; 112: 314-318.
30. ZIEGLER AG. Predicting type I diabetes. Diabetes Care 1990; 13: 762-767.
31. CHASE HP. Prediction of the course of pre-type I diabetes. J Pediatr 1991, 118: 838-841.
32. CARRERAS G, PÉREZ A, MAURICIO D, ORTEGA E, ORTIZ A, DE LEIVA A. Prevalence and characteristics of type 1 diabetes subtypes. Diabetologia 2000; 43 : A 180.
33. PÉREZ-BRAVO F, CARRASCO E, GUTIERREZ-LÓPEZ MD, MARTÍNEZ MT, LÓPEZ G, GARCÍA DE LOS RÍOS M. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children. J Mol Med 1996; 74: 105-9.
34. PARONEN J, BJORKSTEN B, HATTEVIG G, AKERBLOM HK, VAARALA O. Effect of maternal diet lactation on development of bovine insulin-binding antibodies in children at risk for allergy. J Allergy Clin Immunol 2000; 106: 302-6.
35. KIMPIMÄKI T, ERKKOLA M, KORHONEN S, KUPILA A, VIRTANEN SM, ILLONEN J, ET AL. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of type 1 diabetes to progressive beta-cell autoimmunity. Diabetologia 2001; 44: 63-69.